JAG1-NOTCH4 mechanosensing drives atherosclerosis-Reference-Cited by-同舟云学术

JAG1-NOTCH4 mechanosensing drives atherosclerosis

Published:2022-09-02 Issue:35 Volume:8 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Souilhol Celine¹²^ORCID,Tardajos Ayllon Blanca¹^ORCID,Li Xiuying³,Diagbouga Mannekomba R.¹^ORCID,Zhou Ziqi¹^ORCID,Canham Lindsay¹^ORCID,Roddie Hannah¹,Pirri Daniela¹^ORCID,Chambers Emily V.⁴^ORCID,Dunning Mark J.⁴^ORCID,Ariaans Mark¹^ORCID,Li Jin⁵,Fang Yun⁵^ORCID,Jørgensen Helle F.⁶^ORCID,Simons Michael⁷^ORCID,Krams Rob⁸,Waltenberger Johannes⁹¹⁰,Fragiadaki Maria¹,Ridger Victoria¹,De Val Sarah¹¹¹²^ORCID,Francis Sheila E.¹^ORCID,Chico Timothy JA¹,Serbanovic-Canic Jovana¹^ORCID,Evans Paul C.¹^ORCID

Affiliation:

1. Department of Infection, Immunity and Cardiovascular Disease, INSIGNEO Institute for In Silico Medicine, and the Bateson Centre, University of Sheffield, Sheffield, UK.

2. Biomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield, UK.

3. School of Pharmacy, Southwest Medical University, LuZhou, Sichuan 646000, P.R. China.

4. Sheffield Bioinformatics Core, Sheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK.

5. Biological Sciences Division, Department of Medicine, University of Chicago, Chicago, IL, USA.

6. Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke’s Centre for Clinical Investigation, Addenbrooke’s Hospital, Cambridge, UK.

7. Department of Internal Medicine, Yale Cardiovascular Research Center, New Haven, CT, USA.

8. Department of Bioengineering, Queen Mary University of London, London, UK.

9. Department of Cardiovascular Medicine, Medical Faculty, University of Münster, Münster, Germany.

10. Hirslanden Klinik im Park, Cardiovascular Medicine, Diagnostic and Therapeutic Heart Center AG, 8002 Zürich, Switzerland.

11. BHF Centre of Regenerative Medicine, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.

12. Ludwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.

Abstract

Endothelial cell (EC) sensing of disturbed blood flow triggers atherosclerosis, a disease of arteries that causes heart attack and stroke, through poorly defined mechanisms. The Notch pathway plays a central role in blood vessel growth and homeostasis, but its potential role in sensing of disturbed flow has not been previously studied. Here, we show using porcine and murine arteries and cultured human coronary artery EC that disturbed flow activates the JAG1-NOTCH4 signaling pathway. Light-sheet imaging revealed enrichment of JAG1 and NOTCH4 in EC of atherosclerotic plaques, and EC-specific genetic deletion of Jag1 ( Jag1 ECKO ) demonstrated that Jag1 promotes atherosclerosis at sites of disturbed flow. Mechanistically, single-cell RNA sequencing in Jag1 ECKO mice demonstrated that Jag1 suppresses subsets of ECs that proliferate and migrate. We conclude that JAG1-NOTCH4 sensing of disturbed flow enhances atherosclerosis susceptibility by regulating EC heterogeneity and that therapeutic targeting of this pathway may treat atherosclerosis.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference60 articles.

1. Endothelial responses to shear stress in atherosclerosis: a novel role for developmental genes

2. Role of biomechanical forces in the natural history of coronary atherosclerosis

3. Biomechanical factors in atherosclerosis: mechanisms and clinical implications

4. Shear stress: the dark energy of atherosclerotic plaques

5. Notch Signaling: Cell Fate Control and Signal Integration in Development

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of PI5P4Kα slows the progression of aPtenmutant basal cell model of prostate cancer;2024-08-12

2. Regulation of YAP Promotor Accessibility in Endothelial Mechanotransduction;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-03

3. Exercise mitigates flow recirculation and activates metabolic transducer SCD1 to catalyze vascular protective metabolites;Science Advances;2024-02-16

4. Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage;Frontiers in Pharmacology;2024-02-09

5. Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells;Cells;2024-02-05